Bio-Techne

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Bio-Techne and other ETFs, options, and stocks.

About TECH

Bio-Techne Corp. is a global life sciences company providing innovative tools and bioactive reagents for research and clinical diagnostic communities. The firm's products assist scientific investigations into biological processes and the nature and progress of specific diseases. 

CEO
Kim Kelderman
CEOKim Kelderman
Employees
3,000
Employees3,000
Headquarters
Minneapolis, Minnesota
HeadquartersMinneapolis, Minnesota
Founded
1976
Founded1976
Employees
3,000
Employees3,000

TECH Key Statistics

Market cap
11.43B
Market cap11.43B
Price-Earnings ratio
66.56
Price-Earnings ratio66.56
Dividend yield
0.44%
Dividend yield0.44%
Average volume
3.00M
Average volume3.00M
High today
$72.80
High today$72.80
Low today
$72.63
Low today$72.63
Open price
$72.72
Open price$72.72
Volume
1.95M
Volume1.95M
52 Week high
$72.83
52 Week high$72.83
52 Week low
$43.20
52 Week low$43.20

Stock Snapshot

As of today, Bio-Techne(TECH) shares are valued at $72.78. The company's market cap stands at 11.43B, with a P/E ratio of 66.56 and a dividend yield of 0.44%.

As of 2026-11-09, Bio-Techne(TECH) stock has fluctuated between $72.63 and $72.80. The current price stands at $72.78, placing the stock +0.2% above today's low and -0.0% off the high.

The Bio-Techne(TECH)'s current trading volume is 1.95M, compared to an average daily volume of 3M.

In the last year, Bio-Techne(TECH) shares hit a 52-week high of $72.83 and a 52-week low of $43.20.

In the last year, Bio-Techne(TECH) shares hit a 52-week high of $72.83 and a 52-week low of $43.20.

TECH News

Simply Wall St 2d
What Bio-Techne Doubters Overlooked - Simply Wall St

...

What Bio-Techne Doubters Overlooked - Simply Wall St
Simply Wall St 5d
Bio-Techne Stock Trades Above Fair Value On Cash Flow Estimates

has delivered positive returns over the past year, yet the longer track record tells a very different story. That naturally raises the question of whether the c...

Bio-Techne Stock Trades Above Fair Value On Cash Flow Estimates
Zacks 7d
Bio-Techne's Q1 Earnings on Deck: What's in Store for the Stock?

Bio-Techne Corporation (TECH Quick QuoteTECH - Free Report) is expected to release first-quarter fiscal 2027 results soon. The life science and diagnosti...

Bio-Techne's Q1 Earnings on Deck: What's in Store for the Stock?

Analyst ratings

91%

of 11 ratings
Buy
0%
Hold
90.9%
Sell
9.1%

People also own

Based on the portfolios of people who own TECH. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.